Introduction

Pyelectasis refers to the dilation of the renal pelvis, typically identified on prenatal or postnatal imaging. It represents a radiologic finding rather than a diagnosis and can range from transient physiologic variants to early indicators of obstructive uropathy. Pyelectasis may arise from obstructive causes, such as anatomical or functional impairments impeding urinary outflow, or from non-obstructive factors, including increased urine production or bladder dysfunction. Differentiating between these etiologies is essential to prevent long-term renal damage.¹

The identification of an underlying obstructive process is critical in guiding timely intervention and preserving renal function. Two of the most clinically significant obstructive causes of pyelectasis are ureteropelvic junction obstruction (UPJO) and vesicoureteral reflux (VUR). These conditions differ in pathogenesis and clinical management but share the potential for progressive renal compromise if left untreated. This article focuses on the obstructive mechanisms, diagnostic evaluation, and management strategies for UPJO and VUR.

Pathophysiology of Pyelectasis

Under normal physiological conditions, urine produced by the kidneys is transported through the calyces into the renal pelvis, then down the ureters into the bladder for storage and eventual voiding. This flow is unidirectional and maintained by peristalsis, gravity, and competent ureterovesical junctions.

Pyelectasis results when there is impaired urine drainage from the renal pelvis, leading to increased intrapelvic pressure. This pressure can stretch the renal pelvis and, if persistent, may affect renal parenchymal perfusion and function. In obstructive conditions such as UPJO or high-grade VUR, this dilation reflects a pathologic process disrupting the normal flow dynamics.²

Chronic obstruction during critical periods of renal development, especially in utero and infancy, can lead to nephron loss, renal dysplasia, and compromised renal concentrating capacity. Early detection and appropriate management are vital to prevent progression to irreversible renal injury.

Ureteropelvic Junction Obstruction (UPJO)

Ureteropelvic junction obstruction (UPJO) is a condition characterised by impaired drainage of urine from the renal pelvis into the proximal ureter. The obstruction occurs at the ureteropelvic junction (UPJ), the anatomical transition between the renal pelvis and the ureter. It is the most common cause of congenital hydronephrosis and a significant contributor to obstructive uropathy in infants and children.³

Etiology

UPJO may be congenital or acquired, with congenital causes representing the majority of cases. Congenital forms may result from intrinsic narrowing of the UPJ, often due to a segment of aperistaltic or fibrotic tissue, or from extrinsic compression, most commonly by aberrant crossing vessels supplying the lower pole of the kidney. In some instances, a combination of both intrinsic and extrinsic mechanisms is present.⁴
Acquired UPJO can occur secondary to trauma, infection, surgical manipulation, or inflammation, leading to stricture formation. Less frequently, calculi or neoplasms at the UPJ can cause acquired obstruction.

Pathophysiology

In UPJO, functional obstruction results in urine stasis and progressive distension of the renal pelvis. The obstruction impairs antegrade urinary flow, leading to elevated intrapelvic pressures that compromise renal perfusion and, over time, renal parenchymal development and function. The dilated collecting system may also interfere with normal peristalsis, creating a feedback loop that perpetuates obstruction.¹

Clinical Presentation

Antenatally, UPJO is often detected on routine fetal ultrasonography as unilateral or bilateral pyelectasis or hydronephrosis. The anteroposterior diameter (APD) of the renal pelvis serves as a key screening measurement, with thresholds varying by gestational age.

Postnatally, the presentation varies by severity. Many neonates remain asymptomatic and are diagnosed during evaluation for antenatal findings. Symptomatic cases may present later in infancy or childhood with intermittent flank or abdominal pain, particularly during periods of increased diuresis (e.g., after fluid intake). Gross or microscopic hematuria may occur due to mucosal irritation from increased pressure. Urinary tract infections (UTIs), though less common than in VUR, may also occur, especially in cases with concurrent anomalies or poor drainage.³

Vesicoureteral Reflux (VUR)

Vesicoureteral reflux (VUR) is defined as the retrograde flow of urine from the bladder into the ureter and, in some cases, the renal pelvis and calyces. VUR is classified based on the extent of retrograde flow, using a standardised  grading system from I to V on voiding cystourethrogram (VCUG):⁵

• Grade I: Reflux into a non-dilated ureter
• Grade II: Reflux into the renal pelvis without dilation
• Grade III: Mild to moderate dilation of the ureter and renal pelvis
• Grade IV: Moderate dilation and tortuosity of the ureter
• Grade V: Gross dilation and loss of papillary impressions

Etiology

VUR is broadly categorised as primary or secondary. 

• Primary VUR arises from a congenital defect in the ureterovesical junction (UVJ), where inadequate submucosal ureteral tunnelling leads to a failure of the normal valve mechanism. It is often familial and may occur in isolation or with other urinary tract anomalies
• Secondary VUR is typically acquired and results from elevated bladder pressures due to bladder outlet obstruction, neurogenic bladder, or dysfunctional voiding. In these cases, reflux is secondary to structural or functional abnormalities in the lower urinary tract⁵

Pathophysiology

In VUR, the defective UVJ fails to prevent backwards urine flow during bladder filling or voiding. This retrograde flow increases the risk of pyelovenous and pyelolymphatic dissemination of pathogens during urinary tract infections (UTIs). Recurrent febrile UTIs in the presence of VUR are a significant risk factor for renal scarring, particularly in high-grade reflux or when diagnosis is delayed.⁵

Clinical Presentation

Antenatally, VUR may be suspected when hydronephrosis, ureteral dilation, or bladder abnormalities are observed on fetal ultrasonography, though definitive diagnosis requires postnatal imaging. Postnatally, VUR often presents with recurrent febrile UTIs, particularly in infants and young children. Other signs include failure to thrive, irritability, and nonspecific abdominal or flank pain. High-grade VUR and repeated infections may lead to renal scarring, hypertension, and eventual decline in renal function. In some cases, VUR is detected during evaluation of a sibling with known reflux, reflecting its genetic predisposition.⁵

Diagnostic Evaluation

The diagnostic workup of pyelectasis aims to delineate its underlying cause, assess the severity of obstruction or reflux, and evaluate renal function. A structured approach combining imaging and laboratory investigations is essential for guiding management.

• Prenatal ultrasound remains the initial modality for identifying pyelectasis, typically defined by an anteroposterior renal pelvic diameter (APD) exceeding gestational age-specific thresholds. Findings suggestive of obstruction include calyceal dilatation, cortical thinning, and ureteral or bladder abnormalities⁶
• Postnatally, a renal and bladder ultrasound (RBUS) is the first-line imaging tool. It assesses pelvic dilation, ureteral size, bladder wall thickness, and parenchymal integrity. While non-specific, RBUS helps stratify cases requiring further investigation
• A voiding cystourethrogram (VCUG) is the gold standard for diagnosing vesicoureteral reflux. It evaluates the presence and grade of reflux, bladder anatomy, and voiding dynamics. VCUG is especially indicated in infants with febrile UTIs or abnormal RBUS findings
• For suspected ureteropelvic junction obstruction (UPJO), diuretic renal scintigraphy (e.g., MAG3 or DTPA scan) provides both anatomical and functional assessment. It determines the presence and degree of obstruction by evaluating drainage patterns before and after administration of a diuretic agent
• Functional assessment includes nuclear medicine scans, which estimate differential renal function. A reduction in split renal function (<40%) on the affected side may indicate clinically significant obstruction.
• Laboratory evaluation with serum creatinine and urinalysis offers baseline renal function assessment and detection of concurrent infection or hematuria
• In select cases, particularly with a positive family history or bilateral anomalies, genetic and familial evaluation may be considered, as both VUR and UPJO have documented hereditary patterns

Management Approaches

The management of pyelectasis, whether caused by ureteropelvic junction obstruction (UPJO) or vesicoureteral reflux (VUR), involves a comprehensive approach that includes both conservative and surgical strategies, tailored to the severity of the condition and the risk of renal compromise.

Conservative management is often appropriate for mild cases or in infants with transient findings of pyelectasis. Indications for observation include isolated, low-grade VUR (Grades I-III) or mild UPJO without significant impairment of renal function. In these cases, regular monitoring with imaging, including serial renal ultrasounds, is recommended to track changes in renal pelvic dilation or reflux severity.⁶

Antibiotic prophylaxis is commonly used in patients with VUR, especially in young children or those with recurrent urinary tract infections (UTIs). Prophylactic antibiotics reduce the risk of UTIs and prevent renal scarring, particularly in cases of higher-grade reflux. The decision to continue prophylaxis is individualised based on reflux grade, UTI history, and patient risk factors.

Surgical options are considered when conservative management fails or when there is evidence of significant renal damage. For UPJO, pyeloplasty remains the gold standard surgical treatment. This procedure involves the removal of the obstructed segment and reconstruction of the UPJ to restore normal urine flow. Open or minimally invasive techniques, such as robotic-assisted pyeloplasty, are commonly used.⁶

For VUR, surgical correction involves either endoscopic or open surgical correction. Endoscopic procedures, such as subureteral injection of bulking agents, are typically reserved for lower-grade reflux. Open surgery (e.g., ureteral reimplantation) is indicated for higher-grade reflux or failed endoscopic treatments.

Follow-up and monitoring include serial ultrasounds to assess renal dilation and evaluate for any signs of progressive damage. Renal function assessment, including serum creatinine and differential renal scans, ensures that renal function remains intact, particularly in high-risk cases.

Summary

This article explores the obstructive causes of pyelectasis, focusing on two major conditions: ureteropelvic junction obstruction (UPJO) and vesicoureteral reflux (VUR). Pyelectasis, characterised by renal pelvic dilation, can be caused by obstructive or non-obstructive factors. Early identification of obstructive etiologies is critical to prevent renal damage.

UPJO, a common cause of congenital hydronephrosis, results from a functional or structural obstruction at the ureteropelvic junction, leading to impaired urine flow and renal dilation. The condition may be congenital (due to intrinsic stenosis or aberrant vessels) or acquired (due to trauma or inflammation). Clinical presentation varies, with antenatal detection and postnatal symptoms such as pain, UTIs, or hematuria. Management can be conservative, but surgical intervention (pyeloplasty) is indicated for severe or symptomatic cases.

VUR, characterised by the retrograde flow of urine from the bladder into the ureters, can lead to recurrent UTIs and renal scarring. It is classified into five grades based on the severity of reflux, with higher grades associated with a greater risk of renal damage. VUR can be primary (due to congenital UVJ defects) or secondary (due to bladder dysfunction or obstruction). Clinical presentation includes recurrent UTIs, failure to thrive, and potential renal damage. Management strategies range from conservative (antibiotic prophylaxis) to surgical correction (endoscopic or open surgical procedures).

Diagnostic evaluation for both conditions involves imaging techniques such as prenatal ultrasound, renal ultrasound, VCUG, and diuretic renal scintigraphy to assess function and severity. Monitoring includes serial ultrasounds and renal function tests.

FAQs

What is pyelectasis?

Pyelectasis refers to the dilation of the renal pelvis, which is the part of the kidney where urine collects before moving to the ureter. It is often identified during prenatal ultrasound screenings and can be caused by either obstructive or non-obstructive factors.

What are the main causes of pyelectasis?

The two primary obstructive causes of pyelectasis are ureteropelvic junction obstruction (UPJO) and vesicoureteral reflux (VUR). UPJO results from a blockage at the junction where the ureter meets the renal pelvis, while VUR involves the abnormal backwards flow of urine from the bladder into the ureters and kidneys.

How is ureteropelvic junction obstruction (UPJO) diagnosed?

UPJO is often first detected via prenatal ultrasound, showing renal pelvic dilation. Postnatally, further diagnostic imaging, such as a renal ultrasound, voiding cystourethrogram (VCUG), and diuretic renal scintigraphy, is used to assess the severity of the obstruction and kidney function.

What is the treatment for vesicoureteral reflux (VUR)?

The management of VUR depends on the severity of the reflux. For mild cases, conservative treatment such as antibiotic prophylaxis to prevent urinary tract infections (UTIs) is recommended. For more severe cases or recurrent UTIs, surgical interventions such as endoscopic injection or ureteral reimplantation surgery may be required to correct the reflux.

What role does follow-up play in managing pyelectasis caused by UPJO or VUR?

Regular follow-up is essential for monitoring renal function and preventing further damage. This typically involves serial ultrasounds to track changes in renal pelvic dilation and periodic renal function tests, including serum creatinine and nuclear medicine scans, to assess the health of the kidneys.